Health Optimization Index
Vagus Nerve Stimulation
- Nick’s assessment
- Favorable
- Research evidence
- C, mixed evidence
- Attention
- 10.9 / 100▼ Falling this week
BioHarmony score
Vagus nerve stimulation uses implanted or transcutaneous electrical pulses to shift autonomic signaling through vagal afferent pathways. Implanted VNS has narrow medical support for drug-resistant focal epilepsy, while non-invasive tVNS has promising but heterogeneous evidence for HRV, pain, heart failure, insomnia, mood, and inflammation.
Read the full report Benefits, risks and practical guidance.
Read Nick’s assessment Why it earned this rating
Vagus Nerve Stimulation is a 7.0–7.5/10 fit for hrv vagal tone, stress resilience, mood, especially for readers who can match the protocol to device type, stimulation site, autonomic baseline, and contraindications. The best evidence anchors are Duff et al. 2024, which 42 studies; chronic pain meta-analysis favored active auricular VNS, while acute postoperative pooled effect was not statistically significant, and Kong et al. 2024, which 20 clinical trials and 704 epilepsy patients; no significant overall cognitive improvement, with seizure, mood, and quality-of-life improvements. Vagus nerve stimulation uses implanted or transcutaneous electrical pulses to shift autonomic signaling through vagal afferent pathways.
✅ Best for: People with low baseline HRV, chronic stress, autonomic dysregulation, or post-concussion autonomic symptoms who want a passive recovery tool layered on top of breathwork, sleep, and HRV biofeedback. Migraine or cluster-headache patients should look specifically at clinician-guided gammaCore-class cervical nVNS rather than generic wellness devices. Treatment-resistant epilepsy or depression belongs in the implanted VNS medical pathway. Vagus nerve stimulation is also interesting for inflammatory conditions and chronic pain, but the strongest use case is targeted adjunctive care, not broad wellness replacement.
❌ Avoid if: You have a pacemaker, implantable defibrillator, carotid sinus hypersensitivity, bilateral vagotomy, severe bradycardia, second- or third-degree heart block, or unstable cardiac history unless a clinician clears it. Be cautious with beta blockers, verapamil, diltiazem, or digoxin because heart-rate-lowering effects can stack. Avoid consumer tVNS if you expect dramatic, obvious results, already have high HRV and strong vagal tone, or are using FDA and Cochrane signals for implanted VNS to justify an unrelated wellness device.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →